Creative Educational Concepts

🧩 Supporting children with NF1 requires lifelong vigilance.

Join this live symposium to learn how pediatric hematology/oncology nurses can support the early recognition and ongoing management of NF1-associated plexiform neurofibromas (NF1-PNs).

📅 September 17 | 6:15 PM EDT

👉 Register now: https://ce.ceconcepts.com/MMS-165

Livestream: Finding the Right Rhythm: Supporting Pediatric Oncology Nurses in Longitudinal NF1 Management | CE Concepts Management of neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PNs) has evolved rapidly and now includes indications across age groups. NF1 remains a complex, lifelong condition with diverse and evolving manifestations, requiring clinicians to maintain up-to-date knowledge of...

👥 NEPC care requires close collaboration across specialties.

Learn how multidisciplinary coordination between oncology, pathology, radiology, and advanced practice teams improves outcomes.
🔗 https://ce.ceconcepts.com/IN-014

From Resistance to Recognition: Enhancing Care for Neuroendocrine and High-Risk Prostate Cancer Phenotypes | CE Concepts Neuroendocrine prostate cancer (NEPC) and other aggressive histologic variants of prostate cancer (PC) represent rare but clinically devastating disease phenotypes. These tumors progress rapidly and often evade detection through conventional measures such as PSA monitoring and...

Precision oncology continues to evolve in metastatic NSCLC. Antibody-drug conjugates (ADCs) are emerging as powerful targeted therapies—but understanding their mechanisms, biomarkers, and toxicity profiles is essential for clinical application.

Explore expert insights in this recorded CaseWise™ webcast.

👉 View the activity: https://ce.ceconcepts.com/WCV-128

A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC | CE Concepts Antibody-drug conjugates (ADCs) are redefining precision oncology by delivering potent therapies directly to tumor cells through highly specific molecular targeting. This innovative approach is rapidly becoming a cornerstone of cancer care, particularly in metastatic non-small cell...

🧬 RCC treatment is evolving rapidly.

Stay current with the latest clinical trial data and guideline recommendations shaping care for early-stage and advanced renal cell carcinoma.
Explore this recorded CE Concepts Grand Round.
🔗 https://ce.ceconcepts.com/GRV-110

Advances in the Management of Renal Cell Carcinoma: Addressing Gaps and Elevating Care for Patients | CE Concepts Driven by new insights into tumor biology and immune response, the therapeutic landscape for advanced renal cell carcinoma (RCC) continues to rapidly expand. As immunotherapy and VEGF-targeted combinations become central to RCC management, oncology teams must...

Our sister brand Efficient was recognized as a Top Poster Award Winner at OMA 2026! Congratulations to all that made this achievement possible! 🎉

ECME Landing Page Educational Activities Outcomes Poster News Efficient is a dynamic, multifaceted, forward-thinking developer of continuing medical education (CME). The organization was created in response to its belief that many CME activities are underutilized or poorly attended because...

Access to molecular testing and novel therapies remains a challenge in endometrial cancer care.

Explore strategies to reduce disparities and improve equitable access for patients.

👉 View the activity: https://ce.ceconcepts.com/WCV-130

Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies | CE Concepts Despite significant advances in the management of advanced or recurrent endometrial cancer (EC)—including the use of molecular classification, immune checkpoint inhibitors, and targeted therapies—delivering timely, guideline-compliant care remains complex. Rapidly evolving clinical evidence, the...

🔍 Early recognition of VHL-associated tumors can change the disease course.

Gain practical guidance on surveillance, diagnosis, and care coordination for patients with VHL disease.
🔗 https://ce.ceconcepts.com/BC-142

Diagnosis and Multidisciplinary Care of VHL Disease–Associated Tumors | CE Concepts Von Hippel-Lindau (VHL) disease is associated with a range of tumor types that require timely recognition and coordinated management. Accurate diagnosis depends on careful evaluation of clinical presentation, imaging findings, and genetic assessment, as these insights...

👥 Designed for medical oncologists, thoracic oncologists, NPs, PAs, and nurses.

Advance your understanding of next-generation IO agents in metastatic NSCLC.
🔗 https://ce.ceconcepts.com/JC-037

Checkpoint Resistance and Beyond: Unlocking the Promise of Novel IO Agents in mNSCLC | CE Concepts Metastatic non-small cell lung cancer (mNSCLC) remains a leading cause of cancer mortality despite advances with targeted therapy and immune checkpoint inhibitors (ICIs). While PD-1/PD-L1 blockade has improved outcomes, most patients ultimately progress, and durable responses...